Moreover, in certain BCP-ALL cases with unfavorable karyotypes such as dic (9;20), MLLr, and hypodiploidy, evaluation of methylation status of the DR4 and DR5 genes might be clinically informative to predict the efficacy of immunotherapy. The gene discussed is TNFRSF10B; the disease is acute lymphoblastic leukemia.